Anuh Pharma Ltd has informed BSE that it has got approval for Erythromycin Ethyl Succinate and Pyrazinamide following inspection of manufacturing site of Anuh Pharma Ltd on September 16, 2016 by French Naional Agency for Medicines and Health Products Safety (ANSM).
Also, the company got an approval for Pyrazinamide APIMF158 and Sulfadoxine APIMF234 following inspection on September 16, 2016 by World Health Organisation (WHO) Geneva, an official statement added.
The scrip opened at Rs 208.35 and has touched a high and low of Rs 245 and Rs 208.35 respectively. So far 181852(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 512.9 crore.